APA (7th ed.) Citation

Geeraedts, F., Goutagny, N., Hornung, V., Severa, M., Haan, A. d., Pool, J., . . . Huckriede, A. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Geeraedts, Felix, Nadege Goutagny, Veit Hornung, Martina Severa, Aalzen de Haan, Judith Pool, Jan Wilschut, Katherine A. Fitzgerald, and Anke Huckriede. Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine Is Primarily Controlled by Toll-like Receptor Signalling. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Geeraedts, Felix, et al. Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine Is Primarily Controlled by Toll-like Receptor Signalling. Public Library of Science (PLoS).